Li Q - Search Results

1

Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience.

Xu H, Han Y, Wu Y, Wang Y, Li Q, Zhang P, Yuan P, Luo Y, Fan Y, Chen S, Cai R, Li Q, Ma F, Xu B, Wang J. Xu H, et al. Among authors: li q. Front Oncol. 2022 Jun 16;12:906011. doi: 10.3389/fonc.2022.906011. eCollection 2022. Front Oncol. 2022. PMID: 35785207 Free PMC article.

2

[Clinicopathological characteristics and prognostic significance of young patients with triple-negative breast cancer].

Zhang P, Xu BH, Ma F, Li Q. Zhang P, et al. Among authors: li q. Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):128-31. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20403244 Chinese.

3

Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

Fan Y, Xu B, Yuan P, Wang J, Ma F, Li Q, Zhang P, Li Q, Cai R. Fan Y, et al. Among authors: li q. Chemotherapy. 2010;56(4):340-7. doi: 10.1159/000320186. Epub 2010 Aug 18. Chemotherapy. 2010. PMID: 20720418 Clinical Trial.

4

[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].

Zhang P, Xu BH, Ma F, Li Q, Yuan P, Wang JY, Zhang P. Zhang P, et al. Among authors: li q. Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875471 Chinese.

5

[Endobronchial metastases from breast cancer: a clinicopathological and survival analysis].

Li J, Xu BH, Wang JY, Li Q, Zhang P, Yuan P, Ma F, Fan Y, Cai RG, Li Q. Li J, et al. Among authors: li q. Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):394-7. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.018. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22883465 Chinese.

6

[Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].

Yuan P, Xu BH, Wang JY, Ma F, Li Q, Zhang P, Fan Y, Li Q, Wang WM. Yuan P, et al. Among authors: li q. Zhonghua Zhong Liu Za Zhi. 2012 Jun;34(6):465-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.06.014. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22967451 Clinical Trial. Chinese.

7

[Clinical characteristic and management of HER-2 positive node negative small tumor breast cancer (pT1abN0)].

Li Q, Xu BH. Li Q, et al. Zhonghua Yi Xue Za Zhi. 2013 Jan 8;93(2):81-3. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23648339 Chinese. No abstract available.

8

[Effects of polysomy 17 on HER-2 gene and protein expression and its clinicopathologic significance in breast cancer].

Li J, Xu BH, Wang JY, Li Q, Zhang P, Yuan P, Ma F, Fan Y, Cai RG, Li Q. Li J, et al. Among authors: li q. Zhonghua Yi Xue Za Zhi. 2013 Jan 8;93(2):84-8. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23648340 Chinese.

9

[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].

Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q. Li Q, et al. Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23880002 Chinese.

10

[Clinical value of trastuzumab in the treatment of lapatinib-resistant HER2-positive metastatic breast cancer].

Ma F, Xu BH, Li HH, Li Q, Zhang P, Yuan P, Wang JY, Fan Y, Li Q. Ma F, et al. Among authors: li hh, li q. Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):521-4. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24257305 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,077 results

Search Page

Filters